Abstract
We have found several genetic changes in the TGF-beta-type II receptor gene in human gastric cancer cell lines resistant to the growth inhibitory effect of TGF-beta. Southern blot analysis showed deletion of the type II receptor gene in two of eight cell lines and amplification in another two lines. The single cell line we studied that is sensitive to growth inhibition by TGF-beta showed no structural abnormalities of the type II receptor gene. Some of the gastric cancer cells resistant to the growth inhibitory effect of TGF-beta express either truncated or no detectable TGF-beta type II receptor mRNAs, whereas the one that retains responsiveness to the growth inhibitory effect of TGF-beta expresses a full-size type II receptor mRNA. Immunoprecipitation followed by Western blot analysis showed parallel changes in TGF-beta type II receptor expression. Our results suggest that one of the possible mechanisms of escape from autocrine or paracrine growth control by TGF-beta during carcinogenesis could involve genetic changes in the TGF-beta type II receptor gene itself or altered expression of its mRNA.
MeSH Terms
Carcinoma/genetics
DNA, Neoplasm/biosynthesis,genetics
Gene Amplification
Gene Deletion
Gene Expression
Genes
Humans
In Vitro Techniques
Plasminogen Activator Inhibitor 1/genetics
RNA, Messenger/genetics
Receptors, Transforming Growth Factor beta/genetics
Stomach Neoplasms/genetics
Transforming Growth Factor beta/pharmacology
Tumor Cells, Cultured
Chemicals
DNA, Neoplasm
Plasminogen Activator Inhibitor 1
RNA, Messenger
Receptors, Transforming Growth Factor beta
Transforming Growth Factor beta
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Park K
Laboratory of Chemoprevention, National Cancer Institute, Bethesda, MD 20892.
Kim S J
Bang Y J
Park J G
Kim N K
Roberts A B
Sporn M B
References (29)
29 references, click to expand
-
Molecular mechanism of stomach carcinogenesis.
J Cancer Res Clin Oncol. 1993;119(5):265-72
PMID: 8440743
-
Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.
J Biol Chem. 1989 Feb 5;264(4):2272-8
PMID: 2536702
-
Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.
J Natl Cancer Inst. 1991 Jul 3;83(13):938-43
PMID: 1676761
-
Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
Cancer Res. 1992 Jan 15;52(2):295-300
PMID: 1309437
-
Characteristics of cell lines established from human gastric carcinoma.
Cancer Res. 1990 May 1;50(9):2773-80
PMID: 2158397
-
Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas.
Jpn J Cancer Res. 1992 Jan;83(1):86-92
PMID: 1312080
-
Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene.
Nature. 1991 Sep 5;353(6339):83-6
PMID: 1881452
-
Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.
Science. 1993 May 28;260(5112):1344-8
PMID: 8388127
-
Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases.
Trends Cell Biol. 1993 Jan;3(1):14-9
PMID: 14731534
-
Transforming growth factor-beta.
Cancer Surv. 1992;12:81-103
PMID: 1638549
-
Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.
Cancer Res. 1993 Jun 15;53(12):2704-7
PMID: 8389240
-
Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells.
Science. 1988 Apr 8;240(4849):196-9
PMID: 2895499
-
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.
Cell. 1992 Feb 21;68(4):775-85
PMID: 1310899
-
Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.
Cell. 1991 Nov 15;67(4):785-95
PMID: 1657406
-
Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses.
J Biol Chem. 1992 Feb 5;267(4):2588-93
PMID: 1370826
-
Receptors for the TGF-beta family.
Cell. 1992 Jun 26;69(7):1067-70
PMID: 1319842
-
A genetic model for colorectal tumorigenesis.
Cell. 1990 Jun 1;61(5):759-67
PMID: 2188735
-
Growth factors and oncogenes in human gastrointestinal carcinomas.
J Cancer Res Clin Oncol. 1990;116(2):121-31
PMID: 2157713
-
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.
Cancer Res. 1992 Dec 15;52(24):6735-40
PMID: 1458460
-
Autocrine growth factors and cancer.
Nature. 1985 Feb 28-Mar 6;313(6005):745-7
PMID: 3883191
-
cDNA cloning by PCR of rat transforming growth factor beta-1.
Nucleic Acids Res. 1990 May 25;18(10):3059
PMID: 2349108
-
TGF beta signals through a heteromeric protein kinase receptor complex.
Cell. 1992 Dec 11;71(6):1003-14
PMID: 1333888
-
A transforming growth factor beta type I receptor that signals to activate gene expression.
Science. 1994 Jan 7;263(5143):87-9
PMID: 8272871
-
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.
Cell. 1993 Nov 19;75(4):681-92
PMID: 8242743
-
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem. 1987 Apr;162(1):156-9
PMID: 2440339
-
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
Science. 1993 May 28;260(5112):1335-8
PMID: 8388126
-
Expression cloning and characterization of the TGF-beta type III receptor.
Cell. 1991 Nov 15;67(4):797-805
PMID: 1657407
-
Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction.
J Biol Chem. 1990 Oct 25;265(30):18518-24
PMID: 2170414
-
Betaglycan presents ligand to the TGF beta signaling receptor.
Cell. 1993 Jul 2;73(7):1435-44
PMID: 8391934